Cargando…
Intrauterine programming of obesity and type 2 diabetes
The type 2 diabetes epidemic and one of its predisposing factors, obesity, are major influences on global health and economic burden. It is accepted that genetics and the current environment contribute to this epidemic; however, in the last two decades, both human and animal studies have consolidate...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731191/ https://www.ncbi.nlm.nih.gov/pubmed/31451874 http://dx.doi.org/10.1007/s00125-019-4951-9 |
_version_ | 1783449637298896896 |
---|---|
author | Fernandez-Twinn, Denise S. Hjort, Line Novakovic, Boris Ozanne, Susan E. Saffery, Richard |
author_facet | Fernandez-Twinn, Denise S. Hjort, Line Novakovic, Boris Ozanne, Susan E. Saffery, Richard |
author_sort | Fernandez-Twinn, Denise S. |
collection | PubMed |
description | The type 2 diabetes epidemic and one of its predisposing factors, obesity, are major influences on global health and economic burden. It is accepted that genetics and the current environment contribute to this epidemic; however, in the last two decades, both human and animal studies have consolidated considerable evidence supporting the ‘developmental programming’ of these conditions, specifically by the intrauterine environment. Here, we review the various in utero exposures that are linked to offspring obesity and diabetes in later life, including epidemiological insights gained from natural historical events, such as the Dutch Hunger Winter, the Chinese famine and the more recent Quebec Ice Storm. We also describe the effects of gestational exposure to endocrine disruptors, maternal infection and smoking to the fetus in relation to metabolic programming. Causal evidence from animal studies, motivated by human observations, is also discussed, as well as some of the proposed underlying molecular mechanisms for developmental programming of obesity and type 2 diabetes, including epigenetics (e.g. DNA methylation and histone modifications) and microRNA interactions. Finally, we examine the effects of non-pharmacological interventions, such as improving maternal dietary habits and/or increasing physical activity, on the offspring epigenome and metabolic outcomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-019-4951-9) contains a slideset of the figures for download, which is available to authorised users. |
format | Online Article Text |
id | pubmed-6731191 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-67311912019-09-20 Intrauterine programming of obesity and type 2 diabetes Fernandez-Twinn, Denise S. Hjort, Line Novakovic, Boris Ozanne, Susan E. Saffery, Richard Diabetologia Review The type 2 diabetes epidemic and one of its predisposing factors, obesity, are major influences on global health and economic burden. It is accepted that genetics and the current environment contribute to this epidemic; however, in the last two decades, both human and animal studies have consolidated considerable evidence supporting the ‘developmental programming’ of these conditions, specifically by the intrauterine environment. Here, we review the various in utero exposures that are linked to offspring obesity and diabetes in later life, including epidemiological insights gained from natural historical events, such as the Dutch Hunger Winter, the Chinese famine and the more recent Quebec Ice Storm. We also describe the effects of gestational exposure to endocrine disruptors, maternal infection and smoking to the fetus in relation to metabolic programming. Causal evidence from animal studies, motivated by human observations, is also discussed, as well as some of the proposed underlying molecular mechanisms for developmental programming of obesity and type 2 diabetes, including epigenetics (e.g. DNA methylation and histone modifications) and microRNA interactions. Finally, we examine the effects of non-pharmacological interventions, such as improving maternal dietary habits and/or increasing physical activity, on the offspring epigenome and metabolic outcomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-019-4951-9) contains a slideset of the figures for download, which is available to authorised users. Springer Berlin Heidelberg 2019-08-27 2019 /pmc/articles/PMC6731191/ /pubmed/31451874 http://dx.doi.org/10.1007/s00125-019-4951-9 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Fernandez-Twinn, Denise S. Hjort, Line Novakovic, Boris Ozanne, Susan E. Saffery, Richard Intrauterine programming of obesity and type 2 diabetes |
title | Intrauterine programming of obesity and type 2 diabetes |
title_full | Intrauterine programming of obesity and type 2 diabetes |
title_fullStr | Intrauterine programming of obesity and type 2 diabetes |
title_full_unstemmed | Intrauterine programming of obesity and type 2 diabetes |
title_short | Intrauterine programming of obesity and type 2 diabetes |
title_sort | intrauterine programming of obesity and type 2 diabetes |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731191/ https://www.ncbi.nlm.nih.gov/pubmed/31451874 http://dx.doi.org/10.1007/s00125-019-4951-9 |
work_keys_str_mv | AT fernandeztwinndenises intrauterineprogrammingofobesityandtype2diabetes AT hjortline intrauterineprogrammingofobesityandtype2diabetes AT novakovicboris intrauterineprogrammingofobesityandtype2diabetes AT ozannesusane intrauterineprogrammingofobesityandtype2diabetes AT safferyrichard intrauterineprogrammingofobesityandtype2diabetes |